Costs of 4 Months of Rifampin Versus 2 Months of Double-dose Rifampin for Tuberculosis Infection: Post-Hoc Analysis of a Phase 2b Randomized Trial. [PDF]
Romanowski K +10 more
europepmc +1 more source
Evaluation of Methicillin-Resistant <i>Staphylococcus aureus</i> Eradication in People With Cystic Fibrosis. [PDF]
Byerley EM +3 more
europepmc +1 more source
466 RIFAMPIN IN ERADICATION OF METHICILLIN/GENTAMICINRESISTANT S. AUREUS FROM AN NICU [PDF]
Sherry Gardner +3 more
openalex +1 more source
Safety of Triple-Dose Rifampin in Tuberculosis Treatment: A Systematic Review and Meta-Analysis. [PDF]
Arbiv OA +8 more
europepmc +1 more source
1124 Bioavailability of rifampin in children receiving H. Influenzae Chemoprophylaxis [PDF]
Jeffrey R. Koup +3 more
openalex +1 more source
Antimicrobial susceptibility of Legionella gormanii: species-specific ECOFFs, distinct MICs for rifampin versus Legionella pneumophila. [PDF]
Xu JW, He YT, Zhan XY.
europepmc +1 more source
LONG-TERM FOLLOW-UP OF THE RATE OF PHARYNGEAL COLONIZATION WITH HAEMOPHILUS INFLUENZAE TYPE B (Hib) AT A CHRONIC-CARE FACILITY FOLLOWING PROPHYLAXIS WITH RIFAMPIN [PDF]
Eugene D. Shapiro, Ellen R. Wald
openalex +1 more source
The role of innate immunity, antibiotics, and bacteriophages in the course of bacterial infections and their treatment. [PDF]
Berryhill BA +6 more
europepmc +1 more source
Rifampin as a Selective Agent for Isolation of Oral Spirochetes
Susan Leschine, E. Canale‐Parola
openalex +1 more source
Multidrug-Resistant <i>Elizabethkingia anophelis</i> Bacteremia in Northern Taiwan: Focusing on Prognostic Factors and Antimicrobial Susceptibility to Minocycline and Rifampin. [PDF]
Chuang WL, Chang FC, Kuo CF, Lin CC.
europepmc +1 more source

